Advertisement
UK markets close in 7 hours 26 minutes
  • FTSE 100

    8,079.34
    +34.53 (+0.43%)
     
  • FTSE 250

    19,807.14
    +7.42 (+0.04%)
     
  • AIM

    756.36
    +1.49 (+0.20%)
     
  • GBP/EUR

    1.1629
    +0.0001 (+0.01%)
     
  • GBP/USD

    1.2433
    -0.0020 (-0.16%)
     
  • Bitcoin GBP

    53,593.90
    +375.93 (+0.71%)
     
  • CMC Crypto 200

    1,436.42
    +12.32 (+0.86%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CRUDE OIL

    83.37
    +0.01 (+0.01%)
     
  • GOLD FUTURES

    2,334.00
    -8.10 (-0.35%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,155.74
    +326.81 (+1.94%)
     
  • DAX

    18,202.98
    +65.33 (+0.36%)
     
  • CAC 40

    8,108.74
    +2.96 (+0.04%)
     

At US$66.82, Is Cerner Corporation (NASDAQ:CERN) Worth Looking At Closely?

Today we're going to take a look at the well-established Cerner Corporation (NASDAQ:CERN). The company's stock received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US$76.15 at one point, and dropping to the lows of US$66.14. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Cerner's current trading price of US$66.82 reflective of the actual value of the large-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Cerner’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

See our latest analysis for Cerner

Is Cerner still cheap?

The stock seems fairly valued at the moment according to my valuation model. It’s trading around 1.8% below my intrinsic value, which means if you buy Cerner today, you’d be paying a reasonable price for it. And if you believe the company’s true value is $68.08, then there’s not much of an upside to gain from mispricing. Furthermore, Cerner’s low beta implies that the stock is less volatile than the wider market.

What does the future of Cerner look like?

NasdaqGS:CERN Past and Future Earnings, October 7th 2019
NasdaqGS:CERN Past and Future Earnings, October 7th 2019

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Cerner’s earnings over the next few years are expected to increase by 88%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

What this means for you:

Are you a shareholder? CERN’s optimistic future growth appears to have been factored into the current share price, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value?

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping tabs on CERN, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the optimistic prospect is encouraging for the company, which means it’s worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Cerner. You can find everything you need to know about Cerner in the latest infographic research report. If you are no longer interested in Cerner, you can use our free platform to see my list of over 50 other stocks with a high growth potential.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.